SULT2A1 and polycystic ovary syndrome: In clinical practice, serum DHEAS is the most used marker of adrenal hyperandrogenism and, in the past, we and others have reported that about 20–40% of women with PCOS have increased circulating values of this steroid [1,2,3,6,7].